Mid-expiratory flow versus FEV1 measurements in the diagnosis of exercise induced asthma in elite athletes
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2006Submitted date
2007-12
Metadata
Show full item recordAbstract
Backround: A fall in FEV1 of >10% following bronchoprovocation (eucapnic voluntary hyperventilation (EVH) or exercise) is regarded as the gold standard criterion for diagnosing exercise induced asthma (EIA) in athletes. Previous studies have suggested that mid-expiratory flow (FEF50) might be used to supplement FEV1 to improve the sensitivity and specificity of the diagnosis. A study was undertaken to investigate the response of FEF50 following EVH or exercise challenges in elite athletes as an adjunct to FEV1. Methods: Sixty six male (36 asthmatic, 30 non-asthmatic) and 50 female (24 asthmatic, 26 non-asthmatic) elite athletes volunteered for the study. Maximal voluntary flow-volume loops were measured before and 3, 5, 10, and 15 minutes after stopping EVH or exercise. A fall in FEV1 of >10% and a fall in FEF50 of >26% were used as the cut off criteria for identification of EIA. Results: There was a strong correlation between DFEV1 and DFEF50 following bronchoprovocation (r = 0.94, p = 0.000). Sixty athletes had a fall in FEV1 of >10% leading to the diagnosis of EIA. Using the FEF50 criterion alone led to 21 (35%) of these asthmatic athletes receiving a false negative diagnosis. The lowest fall in FEF50 in an athlete with a >10% fall in FEV1 was 14.3%. Reducing the FEF50 criteria to >14% led to 13 athletes receiving a false positive diagnosis. Only one athlete had a fall in FEF50 of >26% in the absence of a fall in FEV1 of >10% (DFEV1 = 8.9%). Conclusion: The inclusion of FEF50 in the diagnosis of EIA in elite athletes reduces the sensitivity and does not enhance the sensitivity or specificity of the diagnosis. The use of FEF50 alone is insufficiently sensitive to diagnose EIA reliably in elite athletes.Citation
Thorax, 61: 111–114Publisher
BMJ PublishingPubMed ID
16227323Additional Links
http://thorax.bmj.com/cgi/content/abstract/61/2/111Type
Journal articleLanguage
enISSN
00406376ae974a485f413a2113503eed53cd6c53
10.1136/thx.2005.046615
Scopus Count
Collections